# Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis

> **NCT00241319** · PHASE3 · COMPLETED · sponsor: **Vistakon Pharmaceuticals** · enrollment: 150 (—)

## Conditions studied

- Allergic Conjunctivitis

## Interventions

- **DRUG:** R89674 (generic name not yet established)

## Key facts

- **NCT ID:** NCT00241319
- **Lead sponsor:** Vistakon Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2005-12
- **Final completion:** —
- **Target enrollment:** 150 (—)
- **Last updated:** 2011-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00241319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00241319, "Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00241319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*